815 Pasquinelli Drive
Westmont, IL. 60559
For appointments call:
Chicago Prostate Cancer Center was established in 1997 with the goal of providing patients with comprehensive care focused on the treatment of prostate cancer with radiation therapy in the form of seed implants (brachytherapy).
The idea was to provide state-of-the-art prostate brachytherapy to our patients with the best equipment and a well-trained staff in a patient-centered facility.
The philosophy of Chicago Prostate Cancer Center is to do what is in the best interest of our patients. We accomplish this by evaluating a patient not only for prostate cancer or elevated PSA levels, but by assessing a patient’s overall health, quality of life and social situation.
Only then can we recommend the best individualized treatment for a patient. This may be prostate radiation with brachytherapy, external beam radiation, hormone therapy, watchful waiting, surgery or a combination of these. In fact historically, we have recommended brachytherapy for our patients in approximately 65% of all cases. This demonstrates our desire to assure that each patient receives the appropriate treatment recommendation for that patient’s individual needs.
In keeping with our intent to provide the best possible prostate cancer treatment for our patients, Chicago Prostate Cancer Center built a new, state of the art 35,000 square foot facility in 2006. The building was designed with the insights gained from more than 10 years experience in performing prostate brachytherapy. After identifying the needs of our patients and staff, we designed the building to meet those needs.
The new Chicago Prostate Cancer Center, filled with the newest and most technologically advanced ultrasound and treatment planning equipment available, also offers an environment where our patients and families can feel comfortable. This design includes a focus on privacy, open areas, light filled waiting rooms and recovery areas, as well as cleanliness and easy access parking. Our mission of making our practice patient-centered is reflected in the 99% excellence rating consistently achieved in patient surveys.
Chicago Prostate Center is also a pioneer in the development of prostate cancer diagnosis, having created the new and highly effective Stereotactic Transperineal Prostate Biopsy (STPB), sometimes referred to as Saturation Biopsy. STPB is performed by taking a median of 40 samples of the prostate through the perineum while the patient is under general anesthesia. Performed as an outpatient procedure, it allows more comprehensive sampling compared to the transrectal method, which takes fewer samples through the rectum. In addition, by taking more samples during STPB, the exact location of the cancer can be pinpointed.
Joan McSweeney, RN.